Correlation Between Pfizer and Senior Connect
Can any of the company-specific risk be diversified away by investing in both Pfizer and Senior Connect at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Senior Connect into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Senior Connect Acquisition, you can compare the effects of market volatilities on Pfizer and Senior Connect and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Senior Connect. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Senior Connect.
Diversification Opportunities for Pfizer and Senior Connect
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pfizer and Senior is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Senior Connect Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Senior Connect Acqui and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Senior Connect. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Senior Connect Acqui has no effect on the direction of Pfizer i.e., Pfizer and Senior Connect go up and down completely randomly.
Pair Corralation between Pfizer and Senior Connect
If you would invest 0.04 in Senior Connect Acquisition on August 29, 2024 and sell it today you would earn a total of 0.00 from holding Senior Connect Acquisition or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 4.35% |
Values | Daily Returns |
Pfizer Inc vs. Senior Connect Acquisition
Performance |
Timeline |
Pfizer Inc |
Senior Connect Acqui |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pfizer and Senior Connect Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and Senior Connect
The main advantage of trading using opposite Pfizer and Senior Connect positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Senior Connect can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Senior Connect will offset losses from the drop in Senior Connect's long position.Pfizer vs. Pharvaris BV | Pfizer vs. Brinker International | Pfizer vs. Alcoa Corp | Pfizer vs. Direxion Daily FTSE |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Fundamental Analysis View fundamental data based on most recent published financial statements |